These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 33710283

  • 41. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E, Chanamara S, Pleasure D, Soulika AM.
    J Neuroinflammation; 2012 Jan 16; 9():7. PubMed ID: 22248039
    [Abstract] [Full Text] [Related]

  • 42. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May 16; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
    Gur-Wahnon D, Mizrachi T, Maaravi-Pinto FY, Lourbopoulos A, Grigoriadis N, Higazi AA, Brenner T.
    J Neuroinflammation; 2013 Oct 11; 10():124. PubMed ID: 24120085
    [Abstract] [Full Text] [Related]

  • 49. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis.
    Okuno T, Nakatsuji Y, Moriya M, Takamatsu H, Nojima S, Takegahara N, Toyofuku T, Nakagawa Y, Kang S, Friedel RH, Sakoda S, Kikutani H, Kumanogoh A.
    J Immunol; 2010 Feb 01; 184(3):1499-506. PubMed ID: 20038643
    [Abstract] [Full Text] [Related]

  • 50. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R, Böttiger G, Stadelmann C, Karnati S, Berghoff M.
    Cells; 2021 Apr 13; 10(4):. PubMed ID: 33924474
    [Abstract] [Full Text] [Related]

  • 51. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ, Hung YF, Liu HY, Hsueh YP.
    Neuroimmunomodulation; 2017 Apr 13; 24(1):29-39. PubMed ID: 28618410
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M, Yamasaki R, Li G, Masaki K, Yamaguchi H, Fujita A, Isobe N, Kira JI.
    Front Immunol; 2018 Apr 13; 9():2588. PubMed ID: 30464764
    [Abstract] [Full Text] [Related]

  • 54. The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation.
    Eitas TK, Chou WC, Wen H, Gris D, Robbins GR, Brickey J, Oyama Y, Ting JP.
    J Biol Chem; 2014 Feb 14; 289(7):4173-9. PubMed ID: 24366868
    [Abstract] [Full Text] [Related]

  • 55. Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation.
    Shaked I, Hanna RN, Shaked H, Chodaczek G, Nowyhed HN, Tweet G, Tacke R, Basat AB, Mikulski Z, Togher S, Miller J, Blatchley A, Salek-Ardakani S, Darvas M, Kaikkonen MU, Thomas GD, Lai-Wing-Sun S, Rezk A, Bar-Or A, Glass CK, Bandukwala H, Hedrick CC.
    Nat Immunol; 2015 Dec 14; 16(12):1228-34. PubMed ID: 26523867
    [Abstract] [Full Text] [Related]

  • 56. The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation.
    Han C, Godfrey V, Liu Z, Han Y, Liu L, Peng H, Weichselbaum RR, Zaki H, Fu YX.
    Sci Immunol; 2021 May 07; 6(59):. PubMed ID: 33963060
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
    Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA.
    Immunity; 2012 Aug 24; 37(2):249-63. PubMed ID: 22884314
    [Abstract] [Full Text] [Related]

  • 59. Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner.
    Heinisch O, Zeyen T, Goldmann T, Prinz M, Huber M, Jung J, Arik E, Habib S, Slowik A, Reich A, Schulz JB, Habib P.
    Transl Stroke Res; 2022 Jun 24; 13(3):462-482. PubMed ID: 34628598
    [Abstract] [Full Text] [Related]

  • 60. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y, Lai L, Chen H, Shi J, Zeng F, Li J, Feng H, Mao J, Zhang F, Wu N, Xu Y, Tan Z, Gong F, Zheng F.
    Mol Immunol; 2018 Sep 24; 101():550-563. PubMed ID: 30173119
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.